Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer's Disease

Completed · Not applicable

Conditions studied: Alzheimer Disease, Caregivers

In brief

A unique multinational study was conducted simultaneously in the USA, England and Australia. The goals of the study were to answer two questions: Does psychosocial support for the family enhance the effectiveness of drug treatment for Alzheimer's disease? Is the added value of psychosocial support the same in all 3 countries?

Key facts

Study ID

NCT00467766

Run by

Pfizer

People needed

300

Starts

1999-07-01

Expected to finish

2003-06-01

Last updated by the study team

2007-05-07

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Individuals diagnosed with mild to moderate stage Alzheimer's disease and their spouse caregivers

You may not qualify if…

• Severe psychological or physical illness
• Unwillingness by either spouse to participate in all aspects of the study

Where it is running

• Aging and Dementia Research Center, Silberstein Institute, NYU School of Medicine — New York, New York, United States
• Prince of Wales Hospital — Randwick, New South Wales, Australia
• University of Manchester, Division of Psychiatry — Manchester, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.